Research prototype, not medical advice.

Rapamycin's side effects on blood sugar come from off-target inhibition of mTORC2, which can be separated from the longevity gain.

Confidence
Established
Level of evidence
Laboratory mammals
Observed in
Mouse
Mission
Map of aging (12 hallmarks)
Concepts
Deregulated nutrient sensingRapamycin (and analogues: everolimus)mTORC2mTOR (mTORC1)

What the sources say

Each row is an article. “Supports”: it backs the claim. “Contradicts”: it goes against it. “Qualifies”: it limits it (another species, a weaker effect…).

DirectionSourceWhere in the articleStatus
Supports Rapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity
Lamming et al. · Science 2012
— Verified